Clinical Trials
Company updates clinical trial programs for therapeutic cancer vaccines
Published in Cancer Weekly, January 3rd, 2006
Transgene announced the opening of the first sites for its phase IIb clinical study with the therapeutic cancer vaccine TG4010 in patients with advanced non small cell lung cancer (NSCLC).
This trial is a randomized, open label and controlled study designed to assess the efficacy of TG4010 in combination with cisplatin and gemcitabine compared to the chemotherapy regimen alone. The trial will enroll 140 patients with stage IIIB or IV non small-cell lung cancer and no prior systemic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-01-03)
More Articles from Cancer Weekly
- Apoptosis
MDM2 antagonists induced apoptosis in acute myeloid leukemia - Serous Cancer
Mean nuclear area used to distinguish low- from high-grade serous carcinomas - Adenovirus Vector
Oncolytic adenovirus replicates selectively in tumors - Adverse Drug Reaction
Papillomavirus-associated squamous cell carcinoma developed in dog after chronic cyclosporine - Amyotrophic Lateral Sclerosis
Motexafin gadolinium improves survival in animal models of ALS - Apoptosis
Antiapoptotic gene is expressed and apoptosis occurs in pituitary adenomas - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
